Coloplast reported 911M in Cash and Equivalent for its fiscal quarter ending in September of 2023.





Cash And Equivalent Change Date
Ambu A/S DKK 691M 44M Mar/2026
Brookdale Senior Living USD 265.2M 13.92M Mar/2026
Cencora USD 2.18B 423.37M Mar/2026
Coloplast 911M 497M Sep/2023
Encompass Health USD 110.5M 38.3M Mar/2026
Enovis USD 33.13M 3.26M Mar/2026
GE HealthCare Technologies USD 2.26B 2.23B Mar/2026
OPKO Health USD 341.88M 27.22M Mar/2026
Pediatrix Medical Group USD 288.88M 83.1M Jun/2026
Veradigm USD 492.6M 7.57M Sep/2022
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026